Total Payments
$70,580
2024 Payments
$493.39
Companies
23
Transactions
434
Medicare Patients
23,982
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$47,800 (67.7%)
Food & Beverage$19,769 (28.0%)
Travel$2,389 (3.4%)
Education$322.56 (0.5%)
Consulting$300.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,800 | 18 | 67.7% |
| Food and Beverage | $19,769 | 387 | 28.0% |
| Travel and Lodging | $2,389 | 13 | 3.4% |
| Education | $322.56 | 15 | 0.5% |
| Consulting Fee | $300.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $45,527 | 94 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $8,675 | 61 | $0 (2024) |
| Abbott Laboratories | $6,903 | 81 | $0 (2023) |
| Boston Scientific Corporation | $2,800 | 33 | $0 (2023) |
| ABIOMED | $2,296 | 25 | $0 (2024) |
| Amgen Inc. | $652.20 | 30 | $0 (2023) |
| CVRx, Inc. | $617.36 | 4 | $0 (2023) |
| Amarin Pharma Inc. | $571.90 | 9 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $571.26 | 17 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $560.81 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $493.39 | 10 | ABIOMED ($324.17) |
| 2023 | $2,301 | 46 | ABIOMED ($676.86) |
| 2022 | $2,567 | 52 | ABIOMED ($1,082) |
| 2021 | $2,853 | 65 | Abbott Laboratories ($1,362) |
| 2020 | $5,304 | 31 | Janssen Pharmaceuticals, Inc ($3,819) |
| 2019 | $19,541 | 64 | Janssen Pharmaceuticals, Inc ($16,837) |
| 2018 | $21,403 | 91 | Janssen Pharmaceuticals, Inc ($10,429) |
| 2017 | $16,118 | 75 | Janssen Pharmaceuticals, Inc ($13,658) |
All Payment Transactions
434 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $119.45 | General |
| Category: Cardiovascular | ||||||
| 09/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $45.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/22/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $54.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/01/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $144.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/04/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/12/2023 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: EMBLEM_CRM | ||||||
| 11/28/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $63.99 | General |
| Category: Cardiology | ||||||
| 11/22/2023 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $64.50 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/13/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Cardiology | ||||||
| 09/22/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/23/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Education | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 08/23/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.94 | General |
| Category: Cardiovascular | ||||||
| 08/18/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $139.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $67.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/11/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.01 | General |
| Category: Cardiovascular | ||||||
| 08/03/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $38.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/27/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $157.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $112.70 | General |
| Category: DIABETES | ||||||
| 07/26/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 9,221 | 13,636 | $1.6M | $587,749 |
| 2022 | 15 | 4,799 | 8,245 | $1.3M | $493,491 |
| 2021 | 15 | 5,127 | 9,342 | $1.5M | $572,250 |
| 2020 | 15 | 4,835 | 8,856 | $1.4M | $507,556 |
Total Patients
23,982
Total Services
40,079
Medicare Billing
$2.2M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,077 | 2,648 | $317,760 | $190,237 | 59.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 894 | 936 | $514,800 | $162,200 | 31.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 310 | 620 | $93,000 | $45,904 | 49.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 630 | 695 | $157,650 | $40,991 | 26.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 218 | 872 | $179,981 | $37,302 | 20.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,066 | 2,377 | $178,275 | $28,118 | 15.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 733 | 1,000 | $12,000 | $8,400 | 70.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 80 | 80 | $14,400 | $7,025 | 48.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 206 | 206 | $9,645 | $5,976 | 62.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 20 | 21 | $8,925 | $3,655 | 41.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 23 | 103 | $8,755 | $3,510 | 40.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 27 | 81 | $8,910 | $3,449 | 38.7% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 207 | 207 | $4,769 | $3,436 | 72.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 206 | 206 | $4,742 | $3,391 | 71.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 22 | 67 | $8,040 | $3,113 | 38.7% |
| 82746 | Folic acid level, serum | Office | 2023 | 207 | 207 | $4,350 | $2,983 | 68.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $5,880 | $2,808 | 47.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 213 | 213 | $4,492 | $2,795 | 62.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 208 | 208 | $4,348 | $2,779 | 63.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 179 | 179 | $3,750 | $2,646 | 70.5% |
| 86141 | Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | Office | 2023 | 208 | 208 | $4,315 | $2,640 | 61.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 85 | 85 | $8,500 | $2,150 | 25.3% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 85 | 85 | $8,500 | $2,122 | 25.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 209 | 209 | $3,260 | $1,990 | 61.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 206 | 206 | $3,396 | $1,821 | 53.6% |
About Dr. Haroutioun Mesrobian, M.D
Dr. Haroutioun Mesrobian, M.D is a Cardiovascular Disease healthcare provider based in Glendale, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477536738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haroutioun Mesrobian, M.D has received a total of $70,580 in payments from pharmaceutical and medical device companies, with $493.39 received in 2024. These payments were reported across 434 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($47,800).
As a Medicare-enrolled provider, Mesrobian has provided services to 23,982 Medicare beneficiaries, totaling 40,079 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Glendale, CA
- Active Since 11/21/2005
- Last Updated 12/13/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1477536738
Products in Payments
- XARELTO (Drug) $45,062
- ENTRESTO (Drug) $8,602
- Impella (Device) $2,296
- RESONATE (Device) $1,627
- Confirm Rx (Device) $907.75
- Merlin Connectivity and Remote (Device) $816.39
- Barostim Neo System (Device) $617.36
- MRI Ready Leads (Device) $613.99
- Vascepa (Drug) $571.90
- CardioMEMS HF System (Device) $548.03
- Repatha (Biological) $543.96
- Quadra Assura CRT Defibrillator (Device) $510.28
- INVOKANA (Drug) $465.67
- CONFIRM RX (Device) $442.52
- Fortify Assura, Ellipse ICD (Device) $441.72
- UPTRAVI (Drug) $397.83
- SQ-RX PULSE GENERATOR (Device) $387.26
- Quadra Allure MP RF CRT Pacemkr (Device) $358.58
- Allure Quadra RF CRT Pacemaker (Device) $340.91
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $305.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Glendale
John Mckenzie, M.d, M.D
Cardiovascular Disease — Payments: $191,549
Cardiovascular Disease $191,549
Hugo Riffel Dalinger, Md, MD
Cardiovascular Disease — Payments: $150,245
Cardiovascular Disease $150,245
Harry Balian, M.d, M.D
Cardiovascular Disease — Payments: $133,783
Cardiovascular Disease $133,783
Truong Duong, Md, MD
Cardiovascular Disease — Payments: $109,744
Cardiovascular Disease $109,744
Dr. Amir Hedayati-Rad, M.d, M.D
Cardiovascular Disease — Payments: $94,643
Cardiovascular Disease $94,643
Dr. Gordi Khera, Md, MD
Cardiovascular Disease — Payments: $87,731
Cardiovascular Disease $87,731